We sought to determine whether Grx1-mediated iNOS could modulate proinflammatory cytokine activation in the pathophysiology of NEC, given that iNOS-derived NO contributes to intestinal inflammation. The gene discussed is GLRX; the disease is necrotizing enterocolitis.